WHO Grants Emergency Use Listing for Cepheid's Xpert® Hemorrhagic Fever Panel Test to Support Ebola Outbreak Response in the DRC

Extensive GeneXpert® Dx system footprint across Africa enables rapid deployment of decentralized molecular testing where it is needed most SUNNYVALE, Calif., Sept. 3, 2026 /PRNewswire/ -- Cepheid, a Danaher company and a leader in molecular diagnostics, today announced that it has...